Search results
Brixton Biosciences secures $33m to develop osteoarthritis pain platform
Clinical Trials Arena via Yahoo Finance· 11 hours agoNeural Ice physically induces a process called Wallerian degeneration when injected into targeted...
Biking revealed to be associated with less knee pain later in life
Medical Xpress· 1 day agoA study published in Medicine & Science in Sports & Exercise reveals that people who participated in...
Diacerein, Resveratrol, Botulinum Toxin Disappoint in Knee OA
Medscape· 7 days agoData do not back the use of diacerein or resveratrol for managing the pain of knee osteoarthritis...
The 8 Best Shoes for Arthritis, According to Podiatrists
Footwear News via Yahoo News· 3 hours agoAlissa Kuizinas, a Massachusetts-based podiatrist. “Osteoarthritis can be due to a previous injury...
How Much Turmeric Should I Take Daily For My Bad Knees? A Review By Nutrition Professionals
MSN News· 1 day agoExpert opinion from Mantwa Radebe Master of Science (MSc) In Nutrition · 12 years of experience ·...
Procedures Commonly Performed at Ambulatory Surgery Centers
US News Health· 21 hours agoTreating fractures or dislocations involves realigning broken bones or correcting bones at the joint in the arm, wrist and hand. Suitable candidates: Patients with acute fractures or dislocations ...
Earnings call: Pacira BioSciences maintains positive outlook in Q1 2024
Investing.com· 7 days agoCEO Frank Lee emphasized the company's progress with its opioid-sparing products, particularly...
Eupraxia Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
FOX 59 Indianapolis· 6 days agoEupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a...
Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com
ETF DAILY NEWS· 7 days agoStockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a research note published on Tuesday morning. The firm issued a sell rating on the stock. Ampio Pharmaceuticals ...
Earnings call: Organogenesis exceeds Q1 expectations, eyes ReNu progress By Investing.com
Investing.com· 4 days agoHoldings Inc. (NASDAQ: NASDAQ:ORGO) has reported a strong start to the year with first quarter...